| Dr Candy Lee Sconyers Lindsey, DO | |
|
415 Fairview Ave, Suite 201, Ponca City, OK 74601-1929 | |
| (580) 762-9355 | |
| (580) 762-9358 |
| Full Name | Dr Candy Lee Sconyers Lindsey |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 415 Fairview Ave, Ponca City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710206313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5099 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Booneville | Booneville, AR | Hospital |
| Mercy Hospital Ozark | Ozark, AR | Hospital |
| North Logan Mercy Hospital | Paris, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Hospital Booneville | 1951530385 | 11 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912955709 PECOS PAC ID: 0244135705 Enrollment ID: O20031206000120 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881642767 PECOS PAC ID: 3678467412 Enrollment ID: O20040211001144 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Ozark |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275504128 PECOS PAC ID: 3678467412 Enrollment ID: O20040428001328 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Waldron |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1912978875 PECOS PAC ID: 5597658005 Enrollment ID: O20061104000294 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1760453633 PECOS PAC ID: 0244135705 Enrollment ID: O20061104000304 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Clinic Fort Smith Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902073620 PECOS PAC ID: 3870668510 Enrollment ID: O20080814000789 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518915321 PECOS PAC ID: 0244135705 Enrollment ID: O20090402000673 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Arkansas Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774630 PECOS PAC ID: 3274681341 Enrollment ID: O20090501000014 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Clinic Fort Smith Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699070649 PECOS PAC ID: 3870668510 Enrollment ID: O20110303000543 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1992133714 PECOS PAC ID: 1951530385 Enrollment ID: O20140312001275 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Entity Name | Mercy Hospital Booneville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083004733 PECOS PAC ID: 1951530385 Enrollment ID: O20170203001490 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Candy Lee Sconyers Lindsey, DO 415 Fairview Ave, Suite 201, Ponca City, OK 74601-1929 Ph: (580) 762-9355 | Dr Candy Lee Sconyers Lindsey, DO 415 Fairview Ave, Suite 201, Ponca City, OK 74601-1929 Ph: (580) 762-9355 |
News Archive
It is likely that the protein is also highly significant for other inflammatory diseases. The research results have been published in the American journal Gastroenterology.
Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.
Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced today that it has formed a collaboration with GSK to explore how Insilico's AI capability can enhance its drug discovery process.
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively and provide those patients with more intensive treatment and closer followup.
› Verified 8 days ago
Karen S Adams, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 421 E Hartford Ave, Ponca City, OK 74601 Phone: 580-762-3342 Fax: 580-762-5841 | |
Dr. Mark A Oatman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 154 S Mccord Rd, Ponca City, OK 74604 Phone: 580-747-9039 | |
Monica Dawn Leach, NP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 200 White Eagle Dr, Ponca City, OK 74601 Phone: 580-765-2501 | |
Mark Edward Rigney, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Fairview Ave Ste 1, Ponca City, OK 74601 Phone: 580-765-6647 Fax: 580-765-6699 | |
Bienvenido Dena Paz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 White Eagle Dr, Ponca City, OK 74601 Phone: 580-765-2501 Fax: 580-765-7289 | |
Dr. Brad Alan Liston, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1908 N 14th St Ste 204, Ponca City, OK 74601 Phone: 580-763-5900 Fax: 580-763-5901 | |
Aaron Paul Wilcox, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 Fairview Ave Ste 201, Ponca City, OK 74601 Phone: 580-762-9355 Fax: 580-762-3420 |